Kezar Life Sciences - Latest News and Information
KZR
Kezar Life Sciences develops novel, first-in-class small molecule therapies that target select proteins to regulate cellular pathways, aiming to treat chronic diseases with a focus on liver disease. The company emphasizes protein-targeting approaches to address limitations of existing treatments and seeks to modulate immune and disease-driving pathways. Headquartered in South San Francisco, Kezar operates with a translational research focus and an emphasis on advancing clinical programs in hepatology and related chronic conditions.
No recent news for this company.
